Publicacións en colaboración con investigadores/as de Hospital Universitario La Paz (29)

2024

  1. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 23-32

2023

  1. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

  2. CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts

    World Allergy Organization Journal, Vol. 16, Núm. 6

  3. Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 11, pp. 3407-3413.e1

  4. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288

  5. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  6. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti–IL-5 Biologics: A Real-Life Study

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 1, pp. 37-44

  7. Lung Function Abnormalities and Their Correlation With Clinical Characteristics and Inflammatory Markers in Adult Asthma

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 294-296

  8. Reply to “Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies”

    Journal of Investigational Allergology and Clinical Immunology

  9. Spanish multidisciplinary consensus on the characteristics of severe asthma patients on biologic treatment who are candidates for at-home administration

    Revista Clinica Espanola, Vol. 223, Núm. 3, pp. 154-164

  10. The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 608-611

2022

  1. Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 4, pp. 1020-1028

  2. Inflammatory Remission in T2 Severe Asthma

    FRONTIERS IN ALLERGY

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Seaic specialty forum: Analysis of the current situation of allergology in spain and outlook for the future

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 120-131

2020

  1. Spanish guidelines for diagnosis, management, treatment, and prevention of dress syndrome

    Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 4, pp. 229-253

2018

  1. Consensus document on dog and cat allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 6, pp. 1206-1222

  2. Occupational Asthma, Not a Trivial Disorder and a Source of Fatal and Near-Fatal Events

    Current Treatment Options in Allergy, Vol. 5, Núm. 1

  3. Severe and rare adverse reaction to hydrochlorothiazide

    Revista Alergia Mexico, Vol. 65, Núm. 4, pp. 442-445

2015

  1. After a lifethreatening reaction to filgrastim

    Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 2, pp. 158-160